Table 17. Anti-hypertensive drugs for acute blood pressure-lowering treatment.
Drug | Route and dosage | Onset of action | Duration of action | Side effect | Contraindication |
Nicardipine | 5 mg/h IVD, uptitrate 2.5 mg/h every 15-30 min, maximum 15 mg/h | 5-15 min | 30-40 min | Headache; reflex tachycardia | Liver failure |
Labetalol | 0.25-0.5 mg/kg IVB, 2-4 mg/min IVD | 5-10 min | 3-6 h | Bradycardia; bronchoconstriction | Second or third degree AVB; asthma; bradycardia; HFrEF |
Esmolol | 0.5-1 mg/kg IVB, 50-300 μg/kg/min IVD | 1-2 min | 10-30 min | Bradycardia | Second or third degree AVB; asthma; bradycardia; HFrEF |
Glyceryl trinitrate | 5 mg/d transdermally | 30-60 min | 12-14 h | Allergy | Concomitant PDE-5 inhibitor |
Nitroglycerine | 5-10 μg/min IVD, uptitrate 5 μg/min every 5 min, maximum 200 μg/min | 1-5 min | 3-5 min | Headache; reflex tachycardia | None |
Hydralazine | 10-20 mg IVB, repeat every 4-6 h, maximum 40 mg | 10-20 min | 12 h | Reflex tachycardia; IICP | IICP |
Nitroprusside | 0.3-0.5 μg/min IVD, uptitrate 0.5 μg/min every 5 min, maximum 10 μg/min | Immediate | 1-2 min | Headache; reflex tachycardia; IICP | IICP |
AVB, atrioventricular block; HFrEF, heart failure with reduced ejection fraction; IICP, increased intracranial pressure; IVB, intravenous bolus; IVD, intravenous drip; PDE-5, phosphodiesterase-5.